- Conditions
- Allergy, Peanut, Food Allergy, Food Allergy Peanut, Peanut Allergy, Peanut Hypersensitivity, Peanut-Induced Anaphylaxis
- Interventions
- Antibiotic, Microbial Transplantation Therapy, Oral Immunotherapy (OIT), Placebo (in place of MTT), Placebo (in place of antibiotics)
- Drug · Biological · Other
- Lead sponsor
- Rima Rachid
- Other
- Eligibility
- 12 Years to 17 Years
- Enrollment
- 37 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1033–1056
of 2,126
matching trials from the local directory fallback.
- Conditions
- CLL/SLL, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Small Lymphocytic Lymphoma
- Interventions
- LP-168, Obinutuzumab
- Drug
- Lead sponsor
- Zulfa Omer
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2034
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Allogeneic Stem Cell Transplantation, Autologous Stem Cell Transplantation, Blood Cancers, CAR-T, Gene Therapy, Non-malignant Disease, Solid Tumors
- Interventions
- Not listed
- Lead sponsor
- Center for International Blood and Marrow Transplant Research
- Network
- Eligibility
- Not listed
- Enrollment
- 99,999,999 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2050
- U.S. locations
- 2
- States / cities
- Minneapolis, Minnesota • Milwaukee, Wisconsin
- Conditions
- Small Cell Lung Cancer
- Interventions
- ZG006
- Drug
- Lead sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 6
- States / cities
- Orange, California • Plantation, Florida • Lexington, Kentucky + 3 more
- Conditions
- Healthy Participants, Metabolic Syndrome, Metabolically Abnormal Obesity, Metabolically Healthy Obesity
- Interventions
- inulin
- Dietary Supplement
- Lead sponsor
- Ball State University
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Muncie, Indiana
- Conditions
- Food Allergy in Children
- Interventions
- Food Allergy Mastery Program
- Behavioral
- Lead sponsor
- Children's National Research Institute
- Other
- Eligibility
- 10 Years to 14 Years
- Enrollment
- 240 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Locally Advanced Solid Tumor, Metastatic Solid Tumor
- Interventions
- ACE2016, Cyclophosphamide, Fludarabine, Pembrolizumab
- Drug
- Lead sponsor
- Acepodia Biotech, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 4
- States / cities
- San Diego, California • Denver, Colorado • Nashville, Tennessee + 1 more
- Conditions
- Care Giving Burden, Chronic Pain, Dementia, Pain Management, Palliative Care
- Interventions
- Usual Pain Management Care, Web-based pain management support tool
- Behavioral · Other
- Lead sponsor
- University of Iowa
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Fallopian Tube Disease, Fallopian Tube Patency Tests, Fibroid/Myoma (Uterus/Cervix), Myomectomy
- Interventions
- chromopertubation
- Procedure
- Lead sponsor
- Medstar Health Research Institute
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Chlamydia, Gonorrhea, Sexually Transmitted Disease (STD), Trichomonas Infection
- Interventions
- Self-swab collection PCR test for chlamydia, gonorrhea, trichomonas
- Diagnostic Test
- Lead sponsor
- Queen's Medical Center
- Other
- Eligibility
- 14 Years and older · Female only
- Enrollment
- 75 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Honolulu, Hawaii
- Conditions
- Arthrodesis, Carpal Fusion (Arthrodesis) of the Hand, Carpometacarpal Joint Arthroplasty, Digital Tendon Transfer, Digital Tendon Transfers, Distal Radius Fracture Fixation, Ligament Repair or Reconstruction, Scapholunate Ligament Reconstruction, Small Bone Fragments and Arthrodesis, Ulnar/Radial Collateral Ligament Reconstruction
- Interventions
- Products listed in cohort description
- Device
- Lead sponsor
- Arthrex, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 650 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2025
- U.S. locations
- 5
- States / cities
- Phoenix, Arizona • Tuscon, Arizona • Iowa City, Iowa + 2 more
- Conditions
- B Cell Acute Lymphoblastic Leukemia (B-ALL), B-ALL, Philadelphia Chromosome Negative
- Interventions
- Exercise intervention, Nutrition Intervention
- Behavioral
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Small Intestinal Bacterial Overgrowth
- Interventions
- CapScan collection capsule
- Device
- Lead sponsor
- Envivo Bio Inc
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Mountain View, California
- Conditions
- Hallucinations, Auditory, Psychosis
- Interventions
- Placebo Patch, Rivastigmine Transdermal System, Scopolamine
- Drug
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2032
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
- Interventions
- Artemisia Annua Leaf, placebo
- Dietary Supplement · Other
- Lead sponsor
- National University of Natural Medicine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Hallux Valgus, Metatarsus Adductus
- Interventions
- Treatment of metatarsus adductus and hallux valgus with the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure
- Device
- Lead sponsor
- Treace Medical Concepts, Inc.
- Industry
- Eligibility
- 14 Years to 65 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2030
- U.S. locations
- 9
- States / cities
- Greeley, Colorado • Ankeny, Iowa • Yarmouth, Maine + 6 more
- Conditions
- EGFR Mutant Advanced Non-small Cell Lung Cancer
- Interventions
- JIN-A02
- Drug
- Lead sponsor
- J Ints Bio
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Orange, California
- Conditions
- Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study
- Interventions
- Not listed
- Lead sponsor
- Imugene Limited
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2039
- U.S. locations
- 1
- States / cities
- Culver City, California
- Conditions
- Esophageal Squamous Cell Carcinoma, Head and Neck Cancer, Malignant Melanoma, Small Cell and Non-small Cell Lung Cancer, Solid Tumor, Squamous Cell Carcinoma of Larynx, Squamous Cell Carcinoma of Nasopharynx, Squamous Cell Carcinoma of Oral Cavity, Squamous Cell Carcinoma of Other Specified Sites of Skin
- Interventions
- Chemotherapy Prior to RAPA-201 Therapy, Pembrolizumab (PD-1 Blocking Antibody), RAPA-201 Rapamycin Resistant T Cells
- Drug · Biological
- Lead sponsor
- Rapa Therapeutics LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 37 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 1
- States / cities
- Hackensack, New Jersey
- Conditions
- Food Allergy, Food Allergy in Children
- Interventions
- Omalizumab Injection
- Drug
- Lead sponsor
- National Jewish Health
- Other
- Eligibility
- 1 Year to 55 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Denver, Colorado
- Conditions
- Penicillin Allergy
- Interventions
- Amoxicillin 187.5mg, Amoxicillin 250 MG, Amoxicillin 62.5mg, Placebo
- Drug
- Lead sponsor
- James Tarbox, MD
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 380 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Lubbock, Texas
- Conditions
- Pediatric ALL
- Interventions
- ECG
- Diagnostic Test
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 1 Day to 45 Days
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Adolescent Behavior, Contraception Behavior, Parent-Child Relations, Sexual Behavior, Sexually Transmitted Diseases
- Interventions
- Morehouse Family Health Study's General Health Guide, Morehouse Family Health Study's Parent Toolkit 2.0
- Behavioral
- Lead sponsor
- Child Trends
- Other
- Eligibility
- 12 Years to 15 Years
- Enrollment
- 2,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Cairo, Georgia
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- PLB1004
- Drug
- Lead sponsor
- Avistone Biotechnology Co., Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 81 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 7
- States / cities
- Sacramento, California • Louisville, Kentucky • Omaha, Nebraska + 3 more